Publicação

Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells

Ver documento

Detalhes bibliográficos
Resumo:Despite the development of mutant-selective KRAS inhibitors, colorectal cancer (CRC) responses remain limited, with stable disease and rapid recurrence being common outcomes. The molecular mechanisms enabling CRC cells to tolerate KRAS inhibition and ultimately develop resistance remain poorly understood. Here, we investigated early transcriptional and proteomic responses to KRAS silencing in 3D CRC cell line spheroid models, aiming to identify pathways associated with sensitivity or resistance to KRAS blockade. Cell lines were stratified into KRAS silencing-sensitive (HCT116 and SW480) and -resistant (LS174T and SW837) groups based on spheroid growth, cell cycle progression, and apoptosis induction. Transcriptional profiling revealed the unfolded protein response (UPR) and WNT/β-catenin signaling as pathways specifically upregulated in KRAS silencing-sensitive cells and downregulated in resistant cells. Proteomic analysis of membrane-enriched fractions further supported UPR deregulation, showing a pronounced downregulation of translation-related proteins in sensitive cells. Functional assays validated that the sensitive cell line HCT116 exhibits reduced protein aggregation and lower translational capacity upon KRAS knockdown, consistent with UPR activation. Pharmacological inhibition of IRE1α-mediated UPR signaling did not revert KRAS silencing-induced cell cycle arrest or apoptosis in this cell line. Collectively, our results highlight the UPR activation as an early adaptive response of KRAS-dependent CRC cells to KRAS silencing.
Autores principais:Martins, Flávia
Outros Autores:Machado, Ana L.; Carvalho, Joana; Almeida, Catarina R.; Beck, Hans C.; Carvalho, Ana S.; Backman, Vadim; Matthiesen, Rune; Matthiesen, Rune; Velho, Sérgia
Assunto:General SDG 3 - Good Health and Well-being
Ano:2025
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade Nova de Lisboa
Idioma:inglês
Origem:Repositório Institucional da UNL
_version_ 1868983064494866432
author Martins, Flávia
author2 Machado, Ana L.
Carvalho, Joana
Almeida, Catarina R.
Beck, Hans C.
Carvalho, Ana S.
Backman, Vadim
Matthiesen, Rune
Matthiesen, Rune
Velho, Sérgia
author2_role author
author
author
author
author
author
author
author
author
author_facet Martins, Flávia
Machado, Ana L.
Carvalho, Joana
Almeida, Catarina R.
Beck, Hans C.
Carvalho, Ana S.
Backman, Vadim
Matthiesen, Rune
Matthiesen, Rune
Velho, Sérgia
author_role author
contributor_name_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
iNOVA4Health - pólo NMS
Nature Publishing Group
RUN
country_str PT
creators_json_txt [{\"Person.name\":\"Martins, Flávia\"},{\"Person.name\":\"Machado, Ana L.\"},{\"Person.name\":\"Carvalho, Joana\"},{\"Person.name\":\"Almeida, Catarina R.\"},{\"Person.name\":\"Beck, Hans C.\"},{\"Person.name\":\"Carvalho, Ana S.\"},{\"Person.name\":\"Backman, Vadim\"},{\"Person.name\":\"Matthiesen, Rune\"},{\"Person.name\":\"Matthiesen, Rune\",\"Person.identifier.orcid\":\"0000-0002-6353-2616\"},{\"Person.name\":\"Velho, Sérgia\"}]
datacite.contributors.contributor.contributorName.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
iNOVA4Health - pólo NMS
Nature Publishing Group
RUN
datacite.creators.creator.creatorName.fl_str_mv Martins, Flávia
Machado, Ana L.
Carvalho, Joana
Almeida, Catarina R.
Beck, Hans C.
Carvalho, Ana S.
Backman, Vadim
Matthiesen, Rune
Matthiesen, Rune
Velho, Sérgia
datacite.date.Accepted.fl_str_mv 2025-04-01T00:00:00Z
datacite.date.available.fl_str_mv 2025-05-07T21:35:28Z
datacite.date.embargoed.fl_str_mv 2025-05-07T21:35:28Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv General
SDG 3 - Good Health and Well-being
datacite.titles.title.fl_str_mv Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
dc.contributor.none.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
iNOVA4Health - pólo NMS
Nature Publishing Group
RUN
dc.creator.none.fl_str_mv Martins, Flávia
Machado, Ana L.
Carvalho, Joana
Almeida, Catarina R.
Beck, Hans C.
Carvalho, Ana S.
Backman, Vadim
Matthiesen, Rune
Matthiesen, Rune
Velho, Sérgia
dc.date.Accepted.fl_str_mv 2025-04-01T00:00:00Z
dc.date.available.fl_str_mv 2025-05-07T21:35:28Z
dc.date.embargoed.fl_str_mv 2025-05-07T21:35:28Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10362/182833
dc.language.none.fl_str_mv eng
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv General
SDG 3 - Good Health and Well-being
dc.title.fl_str_mv Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
description Despite the development of mutant-selective KRAS inhibitors, colorectal cancer (CRC) responses remain limited, with stable disease and rapid recurrence being common outcomes. The molecular mechanisms enabling CRC cells to tolerate KRAS inhibition and ultimately develop resistance remain poorly understood. Here, we investigated early transcriptional and proteomic responses to KRAS silencing in 3D CRC cell line spheroid models, aiming to identify pathways associated with sensitivity or resistance to KRAS blockade. Cell lines were stratified into KRAS silencing-sensitive (HCT116 and SW480) and -resistant (LS174T and SW837) groups based on spheroid growth, cell cycle progression, and apoptosis induction. Transcriptional profiling revealed the unfolded protein response (UPR) and WNT/β-catenin signaling as pathways specifically upregulated in KRAS silencing-sensitive cells and downregulated in resistant cells. Proteomic analysis of membrane-enriched fractions further supported UPR deregulation, showing a pronounced downregulation of translation-related proteins in sensitive cells. Functional assays validated that the sensitive cell line HCT116 exhibits reduced protein aggregation and lower translational capacity upon KRAS knockdown, consistent with UPR activation. Pharmacological inhibition of IRE1α-mediated UPR signaling did not revert KRAS silencing-induced cell cycle arrest or apoptosis in this cell line. Collectively, our results highlight the UPR activation as an early adaptive response of KRAS-dependent CRC cells to KRAS silencing.
dirty 0
eu_rights_str_mv openAccess
format article
fulltext.url.fl_str_mv https://run.unl.pt/bitstreams/9bac49d9-8ad9-447a-9b1e-1dd29d94a151/download
id run_431c06563c2dff24f85c3c19ce93f7cb
identifier.url.fl_str_mv http://hdl.handle.net/10362/182833
inst_facet_str urn:organizationAcronym:unl{{{_:::_}}}Universidade Nova de Lisboa
instacron_str unl
institution Universidade Nova de Lisboa
instname_str Universidade Nova de Lisboa
language eng
network_acronym_str run
network_name_str Repositório Institucional da UNL
oai_identifier_str oai:run.unl.pt:10362/182833
organization_str_mv urn:organizationAcronym:unl
person_str_mv Martins, Flávia
Machado, Ana L.
Carvalho, Joana
Almeida, Catarina R.
Beck, Hans C.
Carvalho, Ana S.
Backman, Vadim
Matthiesen, Rune
Matthiesen, Rune
Matthiesen, Rune
https://www.ciencia-id.pt/BB1A-A606-EE77
BB1A-A606-EE77
http://orcid.org/0000-0002-6353-2616
0000-0002-6353-2616
Velho, Sérgia
publishDate 2025
repo_facet_str urn:repositoryAcronym:run{{{_:::_}}}Repositório Institucional da UNL
reponame_str Repositório Institucional da UNL
repository_id_str urn:repositoryAcronym:run
service_str_mv urn:repositoryAcronym:run
spelling engenDespite the development of mutant-selective KRAS inhibitors, colorectal cancer (CRC) responses remain limited, with stable disease and rapid recurrence being common outcomes. The molecular mechanisms enabling CRC cells to tolerate KRAS inhibition and ultimately develop resistance remain poorly understood. Here, we investigated early transcriptional and proteomic responses to KRAS silencing in 3D CRC cell line spheroid models, aiming to identify pathways associated with sensitivity or resistance to KRAS blockade. Cell lines were stratified into KRAS silencing-sensitive (HCT116 and SW480) and -resistant (LS174T and SW837) groups based on spheroid growth, cell cycle progression, and apoptosis induction. Transcriptional profiling revealed the unfolded protein response (UPR) and WNT/β-catenin signaling as pathways specifically upregulated in KRAS silencing-sensitive cells and downregulated in resistant cells. Proteomic analysis of membrane-enriched fractions further supported UPR deregulation, showing a pronounced downregulation of translation-related proteins in sensitive cells. Functional assays validated that the sensitive cell line HCT116 exhibits reduced protein aggregation and lower translational capacity upon KRAS knockdown, consistent with UPR activation. Pharmacological inhibition of IRE1α-mediated UPR signaling did not revert KRAS silencing-induced cell cycle arrest or apoptosis in this cell line. Collectively, our results highlight the UPR activation as an early adaptive response of KRAS-dependent CRC cells to KRAS silencing.application/pdfenDifferential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cellsMartins, FláviaMachado, Ana L.Carvalho, JoanaAlmeida, Catarina R.Beck, Hans C.Carvalho, Ana S.Backman, VadimMatthiesen, RunePersonalMatthiesen, RuneDSpacehttp://dspace.org/items/67181d3c-b83e-4151-9a74-0ea14aeb7f05DSpacehttp://dspace.org/items/67181d3c-b83e-4151-9a74-0ea14aeb7f05MatthiesenRuneCiência IDhttps://www.ciencia-id.ptBB1A-A606-EE77ORCIDhttp://orcid.org0000-0002-6353-2616Scopus Author IDhttps://www.scopus.com9741897800Velho, SérgiaNOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)iNOVA4Health - pólo NMSNature Publishing GroupHostingInstitutionOrganizationalRUNe-mailmailto:run@unl.ptrun@unl.ptISSNIsPartOf2045-2322URNIsPartOfPURE: 115798878URNIsPartOfPURE UUID: 8c38c8a4-12e2-4ffa-a389-c748f3daed07URNIsPartOfScopus: 105003450752DOIIsPartOf10.1038/s41598-025-94549-22025-05-07T21:35:28Z2025-042025-04-01T00:00:00ZHandlehttp://hdl.handle.net/10362/182833http://purl.org/coar/access_right/c_abf2open accessGeneralSDG 3 - Good Health and Well-being8378194 bytesliteraturehttp://purl.org/coar/resource_type/c_6501journal articlehttp://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://run.unl.pt/bitstreams/9bac49d9-8ad9-447a-9b1e-1dd29d94a151/download
spellingShingle Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
Martins, Flávia
General
SDG 3 - Good Health and Well-being
status SINGLETON
subject.fl_str_mv General
SDG 3 - Good Health and Well-being
title Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
title_full Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
title_fullStr Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
title_full_unstemmed Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
title_short Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
title_sort Differential unfolded protein response regulation in KRAS silencing sensitive and innately resistant colorectal cancer cells
topic General
SDG 3 - Good Health and Well-being
topic_facet General
SDG 3 - Good Health and Well-being
url http://hdl.handle.net/10362/182833
visible 1